Quintiles

CRO Quintiles Opens First Prime Site in Asia

Wednesday, July 14, 2010 07:30 AM

Global CRO Quintiles announced a strategic alliance agreement with the University Malaya Medical Centre (UMMC) in Malaysia as part of its Prime Site program, an initiative focused on accelerating the development of new and more effective medicines.

More... »

Quintiles Expands Number of Strategic Site Relationship Managers

Tuesday, June 29, 2010 07:49 AM

After seeing how a little extra contact with investigative sites improved study-start up times and enrollment, Quintiles has doubled its number of strategic site relationship managers (SSRMs) in the past eight months.

More... »

Quintiles Adds Suite of PI3K Biomarker Assays

Monday, June 14, 2010 09:38 AM

Quintiles has expanded its offerings to include a comprehensive suite of biomarker assays to help biopharmaceutical companies investigate the phosphoinositide 3-kinases (PI3K) cancer survival pathway, the focus of numerous anti-cancer therapies under development.

More... »

SCPMG Becomes Quintiles’ Fourth Prime Site

Wednesday, May 26, 2010 08:46 AM

Kaiser Permanente’s Southern California Permanente Medical Group (SCPMG) has just been welcomed into Quintiles’ Global Prime Sites group, becoming one of only four clinical research groups worldwide to make the cut since the program started in 2007.

More... »

Sarah Cannon Names New CFO

Friday, March 19, 2010 07:05 AM

Strategic research organization Sarah Cannon Research Institute (SCRI) appointed Dean Ferrigno as chief financial officer (CFO), replacing Phil Cestaro, who is now president, SCRI Services. SCRI Services specializes in clinical trial administration with a focus on oncology drug development programs. Cestaro, who joined the company in 2006, will continue to be SCRI’s chief information officer in addition to the new position.

More... »

Quintiles Expands Phase I Capacity in London

Thursday, March 11, 2010 07:38 AM

Quintiles expanded its London-based phase I facility by 35 beds, bringing the total number of phase I beds in London to 105 and globally to 385. The CRO said this number will increase even further later this year as a result of the planned opening of a phase I unit in Hyderabad, India. That facility will initially have 50 beds with capacity for 100.

More... »

INC Research Launches Alliance Partnerships Program

Wednesday, February 24, 2010 06:45 AM

Raleigh, N.C.-based CRO INC Research launched an alliance partnerships program to create and manage strategic alliances with pharmaceutical and biotech customers. The company said it hopes to create relationships with customers based on joint strategic objectives rather than service agreements.

More... »

Quintiles Adds Anatomic Pathology Services to China Lab

Tuesday, February 23, 2010 07:49 AM

Quintiles added anatomic pathology to the service offerings it provides at its central laboratory in Beijing, China. The new services complement assay development, digital pathology and core lab offerings, which the Beijing facility already offers to help customers comply with China’s restrictions on tissue import and export.

More... »

Quintiles Partners with Belgium Pharma Movetis in Commercialization Deal

Tuesday, February 2, 2010 06:50 AM

Quintiles has entered into a strategic alliance with Movetis to help sell the Belgium pharma company’s new gastrointestinal product.

More... »

Quintiles Rebrands with ‘New Health’

Monday, January 25, 2010 09:05 AM

Quintiles launched a new brand identity this morning, focused on what the contract research organization (CRO) is calling “The New Health”—the rapidly changing world of biopharma.

More... »